- Home
- PCF vs ARAY Comparison
PCF vs ARAY Comparison
Compare PCF & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCF
- ARAY
- Stock Information
- Founded
- PCF 1987
- ARAY 1990
- Country
- PCF United States
- ARAY United States
- Employees
- PCF N/A
- ARAY N/A
- Industry
- PCF Trusts Except Educational Religious and Charitable
- ARAY Medical/Dental Instruments
- Sector
- PCF Finance
- ARAY Health Care
- Exchange
- PCF Nasdaq
- ARAY Nasdaq
- Market Cap
- PCF 196.9M
- ARAY 180.0M
- IPO Year
- PCF N/A
- ARAY 2007
- Fundamental
- Price
- PCF $6.36
- ARAY $1.82
- Analyst Decision
- PCF
- ARAY Strong Buy
- Analyst Count
- PCF 0
- ARAY 1
- Target Price
- PCF N/A
- ARAY $9.00
- AVG Volume (30 Days)
- PCF 74.8K
- ARAY 659.9K
- Earning Date
- PCF 01-01-0001
- ARAY 01-29-2025
- Dividend Yield
- PCF 10.90%
- ARAY N/A
- EPS Growth
- PCF N/A
- ARAY N/A
- EPS
- PCF N/A
- ARAY N/A
- Revenue
- PCF N/A
- ARAY $444,204,000.00
- Revenue This Year
- PCF N/A
- ARAY $6.64
- Revenue Next Year
- PCF N/A
- ARAY $5.69
- P/E Ratio
- PCF N/A
- ARAY N/A
- Revenue Growth
- PCF N/A
- ARAY N/A
- 52 Week Low
- PCF $5.71
- ARAY $1.40
- 52 Week High
- PCF $6.96
- ARAY $3.05
- Technical
- Relative Strength Index (RSI)
- PCF 25.43
- ARAY 43.76
- Support Level
- PCF $6.30
- ARAY $1.75
- Resistance Level
- PCF $6.86
- ARAY $1.98
- Average True Range (ATR)
- PCF 0.09
- ARAY 0.09
- MACD
- PCF -0.05
- ARAY -0.03
- Stochastic Oscillator
- PCF 10.53
- ARAY 20.51
About PCF High Income Securities Fund
High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective primarily by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.